CB1 antagonists (Merck & Co)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameCB1 antagonists (Merck & Co)
Drug Alias NameCB1 antagonists (Schering-Plough)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsEndocrine System DiseasesObesityNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSchering-Plough Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchering-Plough CorpMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsEndocrine System DiseasesObesityNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A